Attached files
| file | filename |
|---|---|
| EX-5.1 - EX-5.1 - Cullinan Oncology, Inc. | d65950dex51.htm |
| S-1MEF - S-1MEF - Cullinan Oncology, Inc. | d65950ds1mef.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
The Board of Directors
Cullinan Management, Inc.:
We consent to the use of our report dated November 2, 2020, incorporated herein by reference, and to the reference to our firm under the heading “Experts” in the prospectus.
/s/ KPMG LLP
Boston, Massachusetts
January 7, 2021